76 related articles for article (PubMed ID: 11161462)
21. In vivo alterations of IFN regulatory factor-1 and PIAS1 protein levels in cystic fibrosis epithelium.
Kelley TJ; Elmer HL
J Clin Invest; 2000 Aug; 106(3):403-10. PubMed ID: 10930443
[TBL] [Abstract][Full Text] [Related]
22. IFN-gamma inhibits lipopolysaccharide-induced interleukin-1 beta in primary murine macrophages via a Stat1-dependent pathway.
De Boer ML; Hu J; Kalvakolanu DV; Hasday JD; Cross AS
J Interferon Cytokine Res; 2001 Jul; 21(7):485-94. PubMed ID: 11506742
[TBL] [Abstract][Full Text] [Related]
23. Roles of Stat1, Stat2, and interferon regulatory factor-9 (IRF-9) in interferon tau regulation of IRF-1.
Stewart MD; Choi Y; Johnson GA; Yu-Lee LY; Bazer FW; Spencer TE
Biol Reprod; 2002 Feb; 66(2):393-400. PubMed ID: 11804954
[TBL] [Abstract][Full Text] [Related]
24. Mycophenolic acid inhibits activation of inducible nitric oxide synthase in rodent fibroblasts.
Miljkovic Dj; Cvetkovic I; Stosic-Grujicic S; Trajkovic V
Clin Exp Immunol; 2003 May; 132(2):239-46. PubMed ID: 12699411
[TBL] [Abstract][Full Text] [Related]
25. Cell-specific inhibition of inducible nitric oxide synthase activation by leflunomide.
Jankovic V; Samardzic T; Stosic-Grujicic S; Popadic D; Trajkovic V
Cell Immunol; 2000 Feb; 199(2):73-80. PubMed ID: 10698616
[TBL] [Abstract][Full Text] [Related]
26. Identification and partial characterization of FRAG-6, a novel interferon-stimulated gene that is expressed in an IRF-1-INDEPENDENT manner.
Silva AM; Bottrel RL; Reis LF
Cytokine; 1999 Nov; 11(11):813-21. PubMed ID: 10547268
[TBL] [Abstract][Full Text] [Related]
27. STAT1 is essential for antimicrobial effector function but dispensable for gamma interferon production during Toxoplasma gondii infection.
Gavrilescu LC; Butcher BA; Del Rio L; Taylor GA; Denkers EY
Infect Immun; 2004 Mar; 72(3):1257-64. PubMed ID: 14977926
[TBL] [Abstract][Full Text] [Related]
28. Transcribing the cross-talk of cytokine-induced tetrahydrobiopterin synthesis in endothelial cells.
Peterson TE; Katusic ZS
Circ Res; 2005 Feb; 96(2):141-3. PubMed ID: 15692091
[No Abstract] [Full Text] [Related]
29. STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-gamma.
Lee CK; Smith E; Gimeno R; Gertner R; Levy DE
J Immunol; 2000 Feb; 164(3):1286-92. PubMed ID: 10640742
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporin A suppresses the induction of nitric oxide synthesis in interferon-gamma-treated L929 fibroblasts.
Trajković V; Badovinac V; Janković V; Samardzic T; Maksimović D; Popadić D
Scand J Immunol; 1999 Feb; 49(2):126-30. PubMed ID: 10075015
[TBL] [Abstract][Full Text] [Related]
31. Dysregulation of IFN-gamma signaling pathways in the absence of TGF-beta 1.
McCartney-Francis NL; Wahl SM
J Immunol; 2002 Nov; 169(10):5941-7. PubMed ID: 12421979
[TBL] [Abstract][Full Text] [Related]
32. Long-term suppression of tumor growth by TNF requires a Stat1- and IFN regulatory factor 1-dependent IFN-gamma pathway but not IL-12 or IL-18.
Wu TH; Pabin CN; Qin Z; Blankenstein T; Philip M; Dignam J; Schreiber K; Schreiber H
J Immunol; 2004 Mar; 172(5):3243-51. PubMed ID: 14978132
[TBL] [Abstract][Full Text] [Related]
33. STAT1 plays an essential role in LPS/D-galactosamine-induced liver apoptosis and injury.
Kim WH; Hong F; Radaeva S; Jaruga B; Fan S; Gao B
Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G761-8. PubMed ID: 12816762
[TBL] [Abstract][Full Text] [Related]
34. The immune response modifier imiquimod requires STAT-1 for induction of interferon, interferon-stimulated genes, and interleukin-6.
Bottrel RL; Yang YL; Levy DE; Tomai M; Reis LF
Antimicrob Agents Chemother; 1999 Apr; 43(4):856-61. PubMed ID: 10103191
[TBL] [Abstract][Full Text] [Related]
35. Tumor cell-specific inhibition of inducible nitric oxide synthase activation by tiazofurin.
Samardzic T; Stosic-Grujicic S; Raicevic N; Trajkovic V
Int Immunopharmacol; 2001 Apr; 1(4):795-802. PubMed ID: 11357892
[TBL] [Abstract][Full Text] [Related]
36. Maturation-dependent sequential expression of interferon regulatory factor-1 and inducible nitric oxide synthase in cultured human enterocytes.
Bernstein T; Szabó C; Salzman AL
Shock; 2000 Nov; 14(5):514-21. PubMed ID: 11092683
[TBL] [Abstract][Full Text] [Related]
37. Altered immune response of interferon regulatory factor 1-deficient mice against Plasmodium berghei blood-stage malaria infection.
Tan RS; Feng C; Asano Y; Kara AU
Infect Immun; 1999 May; 67(5):2277-83. PubMed ID: 10225884
[TBL] [Abstract][Full Text] [Related]
38. Interferon regulatory factor 1 in mycobacterial infection.
Yamada H; Mizuno S; Sugawara I
Microbiol Immunol; 2002; 46(11):751-60. PubMed ID: 12516771
[TBL] [Abstract][Full Text] [Related]
39. The role of interleukin-17 in inducible nitric oxide synthase-mediated nitric oxide production in endothelial cells.
Miljkovic Dj; Cvetkovic I; Vuckovic O; Stosic-Grujicic S; Mostarica Stojkovic M; Trajkovic V
Cell Mol Life Sci; 2003 Mar; 60(3):518-25. PubMed ID: 12737311
[TBL] [Abstract][Full Text] [Related]
40. Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1.
Tada Y; Ho A; Matsuyama T; Mak TW
J Exp Med; 1997 Jan; 185(2):231-8. PubMed ID: 9016872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
